Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,155,894
-$13,438,086 QoQ
Shares Held
737,697
-52.7% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#49
of 687 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. RVMD ranks #13 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in RVMD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,155,894 | 737,697 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $151,593,980 | 1,558,807 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,591,192 | 421,735 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $425,296 | 9,107 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $1,038,288 | 22,895 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $883,199 | 22,757 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $810,810 | 25,157 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,579,966 | 89,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,057,011 | 74,314 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,987,525 | 74,300 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,247,441 | 103,760 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $647,904 | 27,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,730,312 | 138,454 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,062,282 | 54,504 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,593,874 | 140,881 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,207,790 | 127,445 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,120,569 | 113,434 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,866,122 | 121,806 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $942,008 | 20,532 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||